Temporal Trends in Acute Adrenal Insufficiency Events in Children With Congenital Adrenal Hyperplasia During

Xanthippi Tseretopoulou1,2, Salma R Ali1,2, Jillian Bryce2

  • 1Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow G51 4TF, UK.

PubMed

Insights

Targeted monitoring in congenital adrenal hyperplasia (CAH) showed a decrease in sick day episodes (SDEs) and hospitalizations. These findings suggest the I-CAH Registry can track clinical benchmarks, but require careful interpretation and long-term observation.

Area of Science:

  • Pediatric Endocrinology
  • Rare Disease Research
  • Clinical Trial Monitoring

Background:

  • Congenital adrenal hyperplasia (CAH) management involves monitoring for acute adrenal insufficiency (AI) related adverse events (AE), including sick day episodes (SDEs) and hospitalizations.
  • The impact of targeted monitoring on the occurrence of these AI-related AEs in CAH patients remains unclear.

Purpose of the Study:

  • To investigate temporal trends of AI-related adverse events (AE) within the I-CAH Registry.
  • To assess whether targeted monitoring is associated with changes in SDEs and hospitalization rates in children with CAH.

Main Methods:

  • Data from children under 18 with 21-hydroxylase deficiency CAH in the I-CAH Registry were collected in 2022 and compared to data from 2019.
  • A total of 513 children across 38 centers in 21 countries were evaluated over a 3-year period (2019-2022).
  • Statistical analysis compared SDE rates and hospitalization rates due to SDEs between the 2019 and 2022 cohorts, adjusting for relevant factors.

Main Results:

  • The median SDE rate per patient year decreased significantly from 0.3 in 2019 to 0 in 2022 (P = .01), even after adjustment.
  • Hospitalization rates due to SDEs also decreased, with 22% of SDEs leading to hospitalization in 2022 compared to 27% in 2019 (P = .02).
  • Of the 38 centers, 62% showed a reduction in SDE rates between the two periods.

Conclusions:

  • The I-CAH Registry serves as a valuable tool for targeted monitoring of critical clinical benchmarks in CAH.
  • While a reduction in SDEs and hospitalizations was observed, these changes necessitate careful interpretation and continued long-term monitoring.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
2.3K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
59.7K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
750
Anatomy of the Adrenal Glands01:17

Anatomy of the Adrenal Glands

The adrenal or supra-renal glands, situated above the kidneys and aligned with the twelfth rib, are paired pyramid-shaped structures crucial for the body's stress response. During stress, these glands secrete hormones vital for adaptive physiological reactions.
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
2.0K